Issues
-
Cover Image
Cover Image
Structure of a p53 tetramer bound to the natural response element of the CDKN1A gene. The p53 tumor suppressor protein is inactivated in more than half of all human cancers. Although several p53-DNA structures have been determined, none of them includes a natural response element. The availability of a well-behaved p53 protein has allowed the determination of a structure containing four p53 subunits bound to the natural p53 response element of the CDKN1A gene. The structure reveals a marked conformational switch in loop L1 of the p53 DNA-binding domain that is even more extensive than the one previously observed in complexes of p53 with artificial consensus response elements. For further details, please see article by Emamzadah and coworkers on page 1493 in this issue. - PDF Icon PDF LinkTable of Contents
Molecular Cancer Research
Table of Contents
Highlights
Reviews
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cell Cycle, Cell Death, and Senescence
Signaling and Regulation
Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.